We Communicate Your Leadership Thoughts
We Communicate Your Leadership Thoughts
K. Anand , CEO & Managing Director, Qualiminds
One of the major pillars of our healthcare system, the Indian Pharmaceutical sector is the third largest across the world in terms of volume and is one of the leading generic medicine contributors in the US and Europe markets. Due to the excellent support and encouragement from the Indian government, even though many startups, as well as SMEs, are venturing into pharmaceutical sectors, they hardly have the expertise or tools to meet the ever-evolving regulatory requirements across the world. After more than 35 years in the pharmaceutical sector, K. Anand started his pharma consulting firm to help Indian pharmaceutical companies meet up regulatory challenges and compliance standards across the world. Under his sharp expertise and able leadership, the firm has been helping pharmaceutical firms grow their market base across the world while maintaining the highest product quality standards and procedures.
A Paradigm Shift in Pharma
By: Sujith Vasudevan, Managing Editor
One of the silver linings of the pandemic has been the catalytic effect it caused in the pharmaceutical and life sciences segment. Despite the havoc it created in the healthcare domain with the excessive number of patients against the lack
Pradeep Singh Kharola Appointed As CMD Of India Trade Promotion Organization
By: CEOInsights Team
Former Civil Aviation Secretary Pradeep Singh Kharola was appointed as the Chairman and Managing Director of India Trade Promotion Organization (ITPO), a Personnel Ministry
By: Ravi Mulugu, Partner, UL
Valuation is a sensitive topic for both the investor and the entrepreneur and both sides work hard to optimize it. In general, the greater the risk, the lower the valuation. A startup by definition is working
By: Dr. Kaushik Sengupta, Product Head Food SAR Region, Bureau Veritas Group
The impact of the COVID-19 pandemic has demonstrated the value of IT and digital transformation across industries and businesses
By: Chandra Reddy, CEO, Altran India
Ancient inventions of basic tools, objects and machines like wheels and pulleys laid the foundations of the word `Engineering' as we know it today. Deploying mechanical principles
By: Hersh Shah, Founder, ITI EdVest
Contribution to the private education sector is majorly in the form of colleges, universities, coaching classes and K-12 schools. The exceptional growth in these segments is attributable to the active participation
By: Benjamin Boesch, Chief Digital Officer, VFS Global
The world is on the move again. After months of closures, the revival of various sectors is evident; re-opening of universities, hybrid working models, and high profile international events are back on the calendar. While these are all signs
By: Mradul K., VP - Global Sales & Strategy, LogiNext
Traditionally, logistics management has typically been a process that has been handled manually, or on separate pieces of software. Despite being a process that handles scale-fleets numbering
Top 10 CEOs from Pharma & Life Sciences – 2022
Given the increasing criticality in healthcare industry impelled by rising health and chronic diseases, pharma and life sciences industry has witnessed prolific attention today. Reimagining the future of pharma and life sciences, the pharma companies have been experiencing a wave of innovations through introduction of new treatment modalities, smart machines, advanced analytics, and essentially, digital connectivity.
The Indian Pharmaceuticals sector has seen some major developments, investments and support from the government in the recent years. India's domestic pharmaceutical market stood at $42 billion in 2021 and is likely to reach $65 billion by 2024 and further expand to reach $120-130 billion by 2030. India is a major exporter of Pharmaceuticals, with over 200+ countries served by Indian pharma exports. India supplies over 50 percent of Africa's requirement for generics, 40 percent of generic demand in the US, and 25 percent of all medicine in the UK. Additionally, as per IBEF, as of 2021, India's biotech industry clocks in about $12 billion in annual revenue.
The Indian biotechnology industry is expected to reach $150 billion by 2025, where its contribution the global biotechnology market will be growing by 19 percent. Significantly, provided the multiple disciplines and functions it serves, Pharma and Life Sciences industry require medical and nonmedical professionals' assistance with equal urgency over time. Hence the CEOs in Pharma and Life Sciences are dynamically looking into augmenting growth within the industry strengthening the pharma and life sciences operations strategy. They definitely need to applauded for it.
In this issue of the CEO Insights magazine, a list of `Top 10 CEOs from Pharma & Life Sciences - 2022' is provided to the readers in corporate and different sectors, for informing on the excellent services leveraged by the Leaders in Pharma and Life Sciences sector. The listing is prepared by a team of industry veterans, CEOs and VCs, and the CEO Insights magazine editorial board.
Our subscribers play a decisive role in finalization of our annual list of "Top 10 CEOs from Pharma & Life Sciences – 2022" by nominating those which have served them with excellence and are praiseworthy. If you feel there is a company that deserves to be on our annual list, do write to us about them mentioning their value proposition.
| Company Logo | Company Management | Company Name | Company Description |
|---|---|---|---|
 |
K. Anand, CEO & Managing Director | Qualiminds | After an accomplished career of over 35 years in the Pharmaceutical sector, he started his pharma consulting firm in 2016 to help organizations raise their quality and regulatory standards while growing their market space |
 |
Balmiki Prasad Singh, Executive Director | Alkem Laboratories | He is currently associated with three Companies and is director with Alkem Foundation who is dedicated in his work |
 |
Glenn Saldanha, Chief Executive Officer | Glenmark Pharmaceuticals | A global leader in pharmaceutical industry driving Glenmark's innovation agenda, discovery & development of transformational healthcare solutions & navigating operational excellence for the last two decades |
 |
Kiran S. Divi, Chief Executive Officer | Divi's Laboratories | As a Chief Executive officer, he has an extensive experience in leading the firm with his strategic planning |
 |
Dr. Niriee Srikant, CEO | Nutri Newron Pediatrix | He successfully introduced a molecular diagnostics technology that has since raised clinicians' awareness of the need for early detection in the fight against fatal illnesses and congenital abnormalities |
 |
Sailesh Desai, Executive Director | Sun Pharmaceutical Industries | Has more than two decades of industrial experience, in which 18 years have been in the pharmaceutical industry |
 |
Sameer Goel, Chief Executive Officer | Kimia Biosciences | As a CEO, he is responsible for overall leadership in accomplishing business and product development goals, as well as the formation of strategic partnerships |
 |
Umang Vohra, Chief Executive Officer | Cipla | He leads Cipla’s transformation journey to build a healthcare ecosystem for the future foray into digital therapeutics & specialty |
 |
Vinita D. Gupta, Chief Executive Officer | Lupin | As a Chief Executive officer, her full focus is to improve the quality and to develop business into next level |
 |
Pradeep Patni, CEO | Akumentis Healthcare | Passionate about developing people and transforming organizational culture, he is an experienced leader with a career spanning more than 25 years in the healthcare industry |
Other Issues
.jpg "What Does IT Take To Be At The Cutting-Edge Of Radiation Oncology Trends?")
.jpg "Sameer Agha: Carving the Best Future for Businesses through Unparalleled Strategies")
.jpg "Reema Shah: Harnessing Intelligent Automation To Enrich Businesses & Empower Clients")
.jpg "Aditya Bothra: An Aspiring Young Entrepreneur Leading Globus Rubchem Group Towards Success")
